Clinical Trials in Spain

• An Open-Label Extension to Study the Long-Term Effect of Dexpramipexole in Participants with Severe Eosinophilic Asthma (EXHALE-5) Under evaluation
  2024-510810-33-00 Phase III Severe eosinophilic asthma Areteia Therapeutics Inc.
• Feasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma Under evaluation
  2024-514991-41-01 Phase II Upper Tract Urothelial Carcinoma. Upper urinary tract transi… European Uro-Oncology Group Stichting
• A Study of Disitamab Vedotin Alone and with Pembrolizumab in Urothelial Cancer That Expresses HER2 Not authorised
  2022-500030-28-00 Phase II Urothelial carcinoma Seagen Inc.
• A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/… Not authorised
  2022-500410-26-00 Phase III Cystic Fibrosis University Medical Center Utrecht
• ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Not authorised
  2022-500535-36-00 Phase III Moderately to severely active ulcerative colitis Abivax
• ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Not authorised
  2022-500536-11-00 Phase III Moderately to severely active ulcerative colitis Abivax
• ABTECT-Maintenance – ABX464 Treatment Evaluation for ulcerative Colitis Therapy Not authorised
  2022-500537-84-00 Phase III Moderately to severely active ulcerative colitis Abivax
• An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl… Not authorised
  2022-501006-34-00 Phase III Liver cirrhosis European Foundation For The Study Of Chronic Liver Failure; Odense University Ho…
• Phase2, double-blind, randomized, placebo-controlled, multicentre study to evaluation the safety, efficacy, and pharmacokinetics of TAK-242 … Not authorised
  2022-501026-37-00 Phase II ACLF is a syndrome that occurs in patients with chronic live… Alpha Bioresearch S.L.; Yaqrit Limited
• Clinical trial of MK-7648A in adults and children with skin cancer Not authorised
  2022-501417-31-00 Phase III High-risk Resected Melanoma Merck Sharp & Dohme LLC
• Phase 3 Study Assessing Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Orbit) Not authorised
  2022-501535-16-00 Phase III Atopic Dermatitis (AD) Amgen Inc.
• A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into… Not authorised
  2022-501644-15-00 Phase II Mild Cognitive Impairment due to Alzheimer's Disease Alzheim… Biogen Idec Research Limited
• A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator’s Choice of Ibrutinib or Acalabrutinib) in Participants… Not authorised
  2022-501697-19-00 Phase III Small Lymphocytic Lymphoma (SLL) / Untreated Chronic Lymphoc… Merck Sharp & Dohme LLC
• KISIMA-02 vaccine-based immunotherapy for patients with mutated pancreatic cancer Not authorised
  2022-501854-12-00 Phase I KRAS G12D/G12V Mutated Pancreatic Ductal Adenocarcinoma Amal Therapeutics S.A.
• A Phase IIIb, Single Arm, Open-label, Multicentre Study of Durvalumab in Combination with Chemotherapy for the First Line Treatment for Pati… Not authorised
  2022-502043-35-00 Phase III Advanced Biliary Tract Cancers AstraZeneca AB
• A clinical study of people with HIV‐1 who switch their treatment to a combination of doravirine and islatravir​​ Not authorised
  2022-502079-49-00 Phase III HIV-1 infection Merck Sharp & Dohme LLC
• A clinical study of people with HIV-1 who have not taken antiretroviral therapy, one group will start treatment with a combination of doravi… Not authorised
  2022-502099-22-00 Phase III HIV-1 Infection Merck Sharp & Dohme LLC
• A clinical study of people with HIV-1 who received prior treatment combination of doravirine and islatravir Not authorised
  2022-502126-40-00 Phase III HIV-1 infection Merck Sharp & Dohme LLC
• A clinical study of people with HIV-1 who take antiretroviral therapy and switch their treatment to a combination of doravirine and islatrav… Not authorised
  2022-502127-22-00 Phase III HIV-1 Infection Merck Sharp & Dohme LLC
• A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major d… Not authorised
  2022-502185-24-00 Phase III Schizophrenia, schizoaffective disorder, schizophreniform di… University Medical Center Utrecht
• MK-0616-013 Not authorised
  2022-502777-42-00 Phase III Hypercholesterolemia Merck Sharp & Dohme LLC
• A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext… Not authorised
  2022-502877-41-00 Phase I/II Pulmonary sarcoidosis with or without extrapulmonary manifes… Xentria Inc.
• Evaluation of the efficacy and safety of eneboparatide (AZP-3601) in patients with chronic hypoparathyroidism (CALYPSO) Not authorised
  2022-503126-12-00 Phase III Hypoparathyroidism Amolyt Pharma
• A Phase I Study of RO7589831 in Participants with Advanced Solid Tumors Not authorised
  2023-503170-20-00 Phase I Advanced solid tumors F. Hoffmann-La Roche AG

Showing 1–24 of 4,846 trials